| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Randomized Controlled Trials as Topic | 3 | 2019 | 510 | 1.070 |
Why?
|
| Diet, Reducing | 6 | 2023 | 106 | 1.000 |
Why?
|
| Cardiovascular Diseases | 5 | 2024 | 1128 | 0.720 |
Why?
|
| Heart Defects, Congenital | 4 | 2020 | 31 | 0.670 |
Why?
|
| Random Allocation | 2 | 2017 | 228 | 0.660 |
Why?
|
| Smoke | 1 | 2019 | 16 | 0.660 |
Why?
|
| Diet, Carbohydrate-Restricted | 4 | 2021 | 5 | 0.660 |
Why?
|
| Food Supply | 3 | 2019 | 67 | 0.640 |
Why?
|
| Nutrition Surveys | 1 | 2019 | 148 | 0.630 |
Why?
|
| Humans | 52 | 2024 | 32114 | 0.610 |
Why?
|
| Treatment Outcome | 10 | 2019 | 3306 | 0.600 |
Why?
|
| Diabetes Mellitus, Type 1 | 3 | 2024 | 251 | 0.570 |
Why?
|
| Diet, Fat-Restricted | 3 | 2023 | 31 | 0.520 |
Why?
|
| Confidence Intervals | 2 | 2017 | 149 | 0.520 |
Why?
|
| Body Weight | 1 | 2017 | 310 | 0.520 |
Why?
|
| Stress, Psychological | 1 | 2017 | 221 | 0.510 |
Why?
|
| Risk Assessment | 3 | 2019 | 1429 | 0.510 |
Why?
|
| Hypertension | 3 | 2021 | 960 | 0.510 |
Why?
|
| Research Design | 1 | 2017 | 315 | 0.490 |
Why?
|
| Obesity | 8 | 2024 | 1176 | 0.470 |
Why?
|
| Female | 35 | 2024 | 20015 | 0.470 |
Why?
|
| Middle Aged | 23 | 2021 | 11839 | 0.450 |
Why?
|
| Intensive Care Units, Neonatal | 3 | 2018 | 33 | 0.450 |
Why?
|
| Male | 30 | 2024 | 19217 | 0.420 |
Why?
|
| Adult | 24 | 2023 | 9380 | 0.410 |
Why?
|
| HIV Infections | 4 | 2017 | 395 | 0.390 |
Why?
|
| Young Adult | 13 | 2024 | 2665 | 0.330 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2024 | 1428 | 0.330 |
Why?
|
| Socioeconomic Factors | 3 | 2019 | 429 | 0.330 |
Why?
|
| Adolescent | 11 | 2024 | 3568 | 0.330 |
Why?
|
| Lipids | 2 | 2021 | 232 | 0.320 |
Why?
|
| Burnout, Professional | 2 | 2021 | 51 | 0.320 |
Why?
|
| Aged | 14 | 2024 | 10314 | 0.310 |
Why?
|
| Insulin Resistance | 3 | 2022 | 462 | 0.300 |
Why?
|
| Retrospective Studies | 10 | 2023 | 3510 | 0.300 |
Why?
|
| Income | 2 | 2017 | 63 | 0.290 |
Why?
|
| Blood Pressure | 3 | 2024 | 845 | 0.270 |
Why?
|
| Weight Loss | 5 | 2023 | 480 | 0.270 |
Why?
|
| Proportional Hazards Models | 4 | 2019 | 753 | 0.250 |
Why?
|
| Triglycerides | 3 | 2021 | 230 | 0.230 |
Why?
|
| Cross-Sectional Studies | 5 | 2020 | 1542 | 0.220 |
Why?
|
| Risk Factors | 9 | 2024 | 3880 | 0.220 |
Why?
|
| Retinal Diseases | 1 | 2023 | 20 | 0.220 |
Why?
|
| Diet Records | 2 | 2019 | 33 | 0.220 |
Why?
|
| Respiratory Tract Infections | 1 | 2023 | 40 | 0.210 |
Why?
|
| Diabetic Retinopathy | 1 | 2023 | 65 | 0.210 |
Why?
|
| Bacterial Infections | 1 | 2023 | 51 | 0.210 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2022 | 4 | 0.210 |
Why?
|
| Polychlorinated Biphenyls | 1 | 2022 | 7 | 0.210 |
Why?
|
| Insulin | 3 | 2022 | 367 | 0.200 |
Why?
|
| Proteomics | 2 | 2020 | 94 | 0.200 |
Why?
|
| Environmental Pollutants | 1 | 2022 | 21 | 0.200 |
Why?
|
| California | 5 | 2020 | 63 | 0.200 |
Why?
|
| Emergency Medicine | 1 | 2023 | 120 | 0.200 |
Why?
|
| Viral Load | 3 | 2016 | 70 | 0.200 |
Why?
|
| Algorithms | 3 | 2019 | 495 | 0.190 |
Why?
|
| Cholesterol, HDL | 2 | 2019 | 177 | 0.190 |
Why?
|
| Breast Feeding | 2 | 2018 | 43 | 0.190 |
Why?
|
| Poverty | 2 | 2019 | 115 | 0.190 |
Why?
|
| Cholesterol, Dietary | 1 | 2021 | 36 | 0.190 |
Why?
|
| Infant | 6 | 2023 | 1062 | 0.190 |
Why?
|
| Child | 7 | 2023 | 2442 | 0.190 |
Why?
|
| Feeding Behavior | 2 | 2019 | 161 | 0.180 |
Why?
|
| Body Mass Index | 3 | 2020 | 923 | 0.180 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2020 | 3 | 0.180 |
Why?
|
| Tricuspid Valve | 1 | 2020 | 5 | 0.180 |
Why?
|
| United States | 5 | 2019 | 3976 | 0.180 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 135 | 0.180 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2020 | 25 | 0.180 |
Why?
|
| Proteome | 1 | 2020 | 39 | 0.170 |
Why?
|
| Mitral Valve | 1 | 2020 | 32 | 0.170 |
Why?
|
| Dental Care for Children | 1 | 2019 | 4 | 0.170 |
Why?
|
| Developmental Disabilities | 1 | 2019 | 18 | 0.170 |
Why?
|
| Aortic Aneurysm | 1 | 2019 | 11 | 0.170 |
Why?
|
| Pulmonary Valve Insufficiency | 1 | 2019 | 4 | 0.170 |
Why?
|
| Aneurysm, Dissecting | 1 | 2019 | 12 | 0.170 |
Why?
|
| Hair | 1 | 2019 | 28 | 0.170 |
Why?
|
| Pulmonary Valve | 1 | 2019 | 11 | 0.170 |
Why?
|
| Hydrocortisone | 1 | 2019 | 57 | 0.170 |
Why?
|
| Cohort Studies | 6 | 2019 | 1817 | 0.170 |
Why?
|
| Workplace | 1 | 2020 | 50 | 0.170 |
Why?
|
| Epidemiologic Methods | 1 | 2019 | 24 | 0.170 |
Why?
|
| Renin-Angiotensin System | 1 | 2021 | 179 | 0.170 |
Why?
|
| Pesticides | 1 | 2022 | 199 | 0.170 |
Why?
|
| Patient Compliance | 3 | 2017 | 225 | 0.170 |
Why?
|
| Hemodynamics | 1 | 2020 | 155 | 0.170 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2020 | 44 | 0.170 |
Why?
|
| Internship and Residency | 1 | 2023 | 313 | 0.170 |
Why?
|
| Pericardium | 1 | 2019 | 52 | 0.170 |
Why?
|
| Secondary Prevention | 1 | 2019 | 63 | 0.170 |
Why?
|
| Causality | 2 | 2019 | 38 | 0.170 |
Why?
|
| Patient Transfer | 1 | 2019 | 43 | 0.170 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2020 | 112 | 0.170 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2019 | 6 | 0.160 |
Why?
|
| Vegetables | 1 | 2019 | 35 | 0.160 |
Why?
|
| Pneumonia | 1 | 2019 | 68 | 0.160 |
Why?
|
| Suture Techniques | 1 | 2019 | 61 | 0.160 |
Why?
|
| Breast Neoplasms | 2 | 2016 | 765 | 0.160 |
Why?
|
| Lymphoma, B-Cell | 1 | 2019 | 11 | 0.160 |
Why?
|
| Dietary Carbohydrates | 1 | 2019 | 22 | 0.160 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2019 | 10 | 0.160 |
Why?
|
| Fruit | 1 | 2019 | 53 | 0.160 |
Why?
|
| Lactation | 1 | 2018 | 16 | 0.160 |
Why?
|
| Logistic Models | 2 | 2019 | 783 | 0.160 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2019 | 73 | 0.160 |
Why?
|
| Health Status Indicators | 1 | 2019 | 73 | 0.160 |
Why?
|
| Genotype | 2 | 2018 | 733 | 0.160 |
Why?
|
| Dietary Fats | 1 | 2019 | 110 | 0.160 |
Why?
|
| Fatty Acids | 1 | 2019 | 98 | 0.160 |
Why?
|
| Lymphocyte Count | 1 | 2018 | 24 | 0.160 |
Why?
|
| Models, Statistical | 1 | 2019 | 175 | 0.160 |
Why?
|
| Medicare | 1 | 2019 | 206 | 0.150 |
Why?
|
| Selenium | 1 | 2017 | 4 | 0.150 |
Why?
|
| Carotenoids | 1 | 2017 | 10 | 0.150 |
Why?
|
| Marital Status | 1 | 2017 | 23 | 0.150 |
Why?
|
| Child, Preschool | 5 | 2020 | 1270 | 0.150 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2017 | 32 | 0.150 |
Why?
|
| Computer Simulation | 2 | 2017 | 220 | 0.150 |
Why?
|
| Graft Survival | 1 | 2019 | 313 | 0.150 |
Why?
|
| Glomerular Filtration Rate | 1 | 2018 | 308 | 0.140 |
Why?
|
| Social Class | 1 | 2017 | 90 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2017 | 55 | 0.140 |
Why?
|
| Group Processes | 1 | 2017 | 15 | 0.140 |
Why?
|
| Organizational Culture | 1 | 2017 | 26 | 0.140 |
Why?
|
| Vitamins | 1 | 2017 | 68 | 0.140 |
Why?
|
| Health Expenditures | 1 | 2017 | 66 | 0.140 |
Why?
|
| Fasting | 1 | 2017 | 95 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2020 | 1328 | 0.140 |
Why?
|
| Milk, Human | 1 | 2016 | 16 | 0.140 |
Why?
|
| Plasma | 1 | 2016 | 14 | 0.140 |
Why?
|
| Antioxidants | 1 | 2017 | 115 | 0.140 |
Why?
|
| Educational Status | 1 | 2017 | 181 | 0.140 |
Why?
|
| Residence Characteristics | 1 | 2018 | 202 | 0.140 |
Why?
|
| Acute Coronary Syndrome | 1 | 2019 | 196 | 0.140 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2016 | 24 | 0.140 |
Why?
|
| Anti-Retroviral Agents | 1 | 2016 | 21 | 0.140 |
Why?
|
| Cross Infection | 1 | 2017 | 55 | 0.140 |
Why?
|
| Software | 1 | 2017 | 123 | 0.140 |
Why?
|
| Radiation Pneumonitis | 1 | 2016 | 4 | 0.140 |
Why?
|
| Health Status | 1 | 2019 | 400 | 0.140 |
Why?
|
| Prisons | 1 | 2016 | 5 | 0.140 |
Why?
|
| Radiology Information Systems | 1 | 2016 | 13 | 0.130 |
Why?
|
| Dietary Supplements | 1 | 2017 | 185 | 0.130 |
Why?
|
| Prisoners | 1 | 2016 | 11 | 0.130 |
Why?
|
| Patient Care Team | 1 | 2017 | 129 | 0.130 |
Why?
|
| Caloric Restriction | 1 | 2017 | 106 | 0.130 |
Why?
|
| Continental Population Groups | 1 | 2017 | 237 | 0.130 |
Why?
|
| Carbamates | 1 | 2015 | 15 | 0.130 |
Why?
|
| Overweight | 3 | 2024 | 280 | 0.130 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2016 | 42 | 0.130 |
Why?
|
| Workload | 1 | 2016 | 40 | 0.130 |
Why?
|
| Internet | 1 | 2017 | 198 | 0.130 |
Why?
|
| Infant, Newborn | 4 | 2019 | 672 | 0.130 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 13 | 0.130 |
Why?
|
| Smoking | 1 | 2020 | 528 | 0.130 |
Why?
|
| Documentation | 1 | 2016 | 46 | 0.130 |
Why?
|
| Heart Failure | 2 | 2019 | 639 | 0.130 |
Why?
|
| Chromosome Aberrations | 1 | 2015 | 23 | 0.130 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2015 | 21 | 0.130 |
Why?
|
| Sulfonamides | 1 | 2015 | 67 | 0.130 |
Why?
|
| Health Policy | 1 | 2016 | 89 | 0.130 |
Why?
|
| Anti-HIV Agents | 1 | 2015 | 55 | 0.130 |
Why?
|
| Positron-Emission Tomography | 1 | 2016 | 163 | 0.130 |
Why?
|
| Diet | 1 | 2017 | 391 | 0.120 |
Why?
|
| Biometry | 1 | 2014 | 13 | 0.120 |
Why?
|
| Hepatitis B Vaccines | 1 | 2014 | 10 | 0.120 |
Why?
|
| Coronary Artery Disease | 1 | 2018 | 401 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 322 | 0.120 |
Why?
|
| Statistics, Nonparametric | 1 | 2014 | 130 | 0.120 |
Why?
|
| Antihypertensive Agents | 1 | 2017 | 352 | 0.120 |
Why?
|
| Lung | 1 | 2016 | 249 | 0.120 |
Why?
|
| Pregnancy | 4 | 2019 | 997 | 0.120 |
Why?
|
| Motivation | 1 | 2014 | 113 | 0.110 |
Why?
|
| Inflammation | 1 | 2017 | 530 | 0.110 |
Why?
|
| Postoperative Complications | 1 | 2019 | 780 | 0.110 |
Why?
|
| Substance-Related Disorders | 1 | 2014 | 128 | 0.110 |
Why?
|
| Mass Screening | 1 | 2016 | 263 | 0.110 |
Why?
|
| Radiosurgery | 1 | 2016 | 356 | 0.100 |
Why?
|
| Lung Neoplasms | 1 | 2016 | 414 | 0.100 |
Why?
|
| Cytosine | 1 | 2011 | 10 | 0.100 |
Why?
|
| Adenoviridae Infections | 1 | 2011 | 13 | 0.100 |
Why?
|
| Immunocompromised Host | 1 | 2011 | 51 | 0.100 |
Why?
|
| Adenoviridae | 1 | 2011 | 66 | 0.100 |
Why?
|
| Reproducibility of Results | 3 | 2020 | 765 | 0.100 |
Why?
|
| Stem Cell Transplantation | 1 | 2011 | 209 | 0.090 |
Why?
|
| Propensity Score | 2 | 2019 | 39 | 0.090 |
Why?
|
| Cholesterol, LDL | 2 | 2021 | 173 | 0.080 |
Why?
|
| Aged, 80 and over | 4 | 2019 | 3990 | 0.080 |
Why?
|
| Hospitalization | 2 | 2023 | 470 | 0.080 |
Why?
|
| Observer Variation | 2 | 2020 | 105 | 0.080 |
Why?
|
| Case-Control Studies | 2 | 2022 | 898 | 0.080 |
Why?
|
| Prospective Studies | 2 | 2024 | 2283 | 0.080 |
Why?
|
| Energy Intake | 2 | 2019 | 128 | 0.080 |
Why?
|
| Databases, Factual | 2 | 2019 | 355 | 0.070 |
Why?
|
| Prevalence | 2 | 2023 | 989 | 0.070 |
Why?
|
| SEER Program | 2 | 2018 | 30 | 0.070 |
Why?
|
| Single-Blind Method | 2 | 2017 | 203 | 0.070 |
Why?
|
| Predictive Value of Tests | 2 | 2020 | 876 | 0.070 |
Why?
|
| Neoplasm Staging | 2 | 2018 | 447 | 0.060 |
Why?
|
| Electronic Health Records | 2 | 2017 | 162 | 0.060 |
Why?
|
| Incidence | 2 | 2019 | 1199 | 0.060 |
Why?
|
| Carbohydrates | 1 | 2023 | 8 | 0.060 |
Why?
|
| Uric Acid | 1 | 2024 | 27 | 0.060 |
Why?
|
| Time Factors | 2 | 2019 | 2151 | 0.060 |
Why?
|
| Manikins | 1 | 2023 | 34 | 0.060 |
Why?
|
| Skin Pigmentation | 1 | 2023 | 26 | 0.050 |
Why?
|
| Tracheostomy | 1 | 2023 | 29 | 0.050 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2022 | 1 | 0.050 |
Why?
|
| Length of Stay | 1 | 2023 | 314 | 0.050 |
Why?
|
| Life Style | 1 | 2024 | 408 | 0.050 |
Why?
|
| Glucose | 1 | 2022 | 174 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2022 | 508 | 0.040 |
Why?
|
| Health Personnel | 1 | 2021 | 121 | 0.040 |
Why?
|
| Respiratory Therapy | 1 | 2019 | 4 | 0.040 |
Why?
|
| Child Behavior | 1 | 2019 | 27 | 0.040 |
Why?
|
| Tennessee | 1 | 2019 | 102 | 0.040 |
Why?
|
| Gastrostomy | 1 | 2019 | 17 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 2019 | 33 | 0.040 |
Why?
|
| Child Development | 1 | 2019 | 43 | 0.040 |
Why?
|
| Nutritional Requirements | 1 | 2019 | 16 | 0.040 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2019 | 1 | 0.040 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2019 | 22 | 0.040 |
Why?
|
| Mice, Inbred NOD | 1 | 2019 | 25 | 0.040 |
Why?
|
| Quinazolinones | 1 | 2019 | 6 | 0.040 |
Why?
|
| Reminder Systems | 1 | 2019 | 22 | 0.040 |
Why?
|
| Reproductive History | 1 | 2018 | 5 | 0.040 |
Why?
|
| Parity | 1 | 2018 | 20 | 0.040 |
Why?
|
| Aorta | 1 | 2019 | 126 | 0.040 |
Why?
|
| Purines | 1 | 2019 | 22 | 0.040 |
Why?
|
| Mice, SCID | 1 | 2019 | 71 | 0.040 |
Why?
|
| Nutrition Assessment | 1 | 2019 | 55 | 0.040 |
Why?
|
| Heart Transplantation | 1 | 2019 | 27 | 0.040 |
Why?
|
| Public Health | 1 | 2020 | 89 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 2019 | 73 | 0.040 |
Why?
|
| Sirolimus | 1 | 2019 | 33 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 263 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2019 | 70 | 0.040 |
Why?
|
| Linear Models | 1 | 2020 | 449 | 0.040 |
Why?
|
| Focus Groups | 1 | 2019 | 118 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2019 | 76 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2019 | 74 | 0.040 |
Why?
|
| Gestational Age | 1 | 2018 | 121 | 0.040 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2018 | 9 | 0.040 |
Why?
|
| Hospital Mortality | 1 | 2019 | 198 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2019 | 472 | 0.040 |
Why?
|
| Qualitative Research | 1 | 2019 | 175 | 0.040 |
Why?
|
| Organ Transplantation | 1 | 2019 | 66 | 0.040 |
Why?
|
| Tocopherols | 1 | 2017 | 3 | 0.040 |
Why?
|
| Mothers | 1 | 2018 | 88 | 0.040 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2017 | 41 | 0.040 |
Why?
|
| Ascorbic Acid | 1 | 2017 | 23 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2019 | 406 | 0.040 |
Why?
|
| Patient Selection | 1 | 2019 | 276 | 0.040 |
Why?
|
| Likelihood Functions | 1 | 2017 | 48 | 0.040 |
Why?
|
| Chemokine CCL2 | 1 | 2017 | 48 | 0.040 |
Why?
|
| Diet Therapy | 1 | 2017 | 15 | 0.040 |
Why?
|
| Graft Rejection | 1 | 2019 | 238 | 0.040 |
Why?
|
| Allied Health Personnel | 1 | 2017 | 3 | 0.040 |
Why?
|
| Nursing Staff, Hospital | 1 | 2017 | 11 | 0.040 |
Why?
|
| Nurses | 1 | 2017 | 15 | 0.040 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2017 | 49 | 0.040 |
Why?
|
| Health Surveys | 1 | 2017 | 198 | 0.040 |
Why?
|
| Survival Rate | 1 | 2019 | 877 | 0.040 |
Why?
|
| Mortality | 1 | 2018 | 125 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 99 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2019 | 324 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 770 | 0.030 |
Why?
|
| Age Factors | 1 | 2020 | 1189 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2017 | 247 | 0.030 |
Why?
|
| Registries | 1 | 2018 | 298 | 0.030 |
Why?
|
| HIV Seroprevalence | 1 | 2016 | 1 | 0.030 |
Why?
|
| New Mexico | 1 | 2016 | 6 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2017 | 525 | 0.030 |
Why?
|
| Radiotherapy Dosage | 1 | 2016 | 101 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 767 | 0.030 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2016 | 50 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2015 | 78 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2017 | 548 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2017 | 145 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2015 | 93 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2015 | 40 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2016 | 147 | 0.030 |
Why?
|
| Genomics | 1 | 2016 | 85 | 0.030 |
Why?
|
| Phenotype | 1 | 2017 | 632 | 0.030 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 184 | 0.030 |
Why?
|
| European Continental Ancestry Group | 1 | 2019 | 1166 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2015 | 288 | 0.030 |
Why?
|
| Physicians | 1 | 2017 | 159 | 0.030 |
Why?
|
| Body Composition | 1 | 2016 | 397 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 190 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2016 | 161 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2017 | 494 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 582 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 161 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 1497 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 2265 | 0.030 |
Why?
|
| Myocardial Infarction | 1 | 2017 | 475 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 408 | 0.030 |
Why?
|
| Mice | 1 | 2019 | 2484 | 0.030 |
Why?
|
| African Americans | 1 | 2019 | 1425 | 0.030 |
Why?
|
| Stroke | 1 | 2017 | 585 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 835 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 151 | 0.020 |
Why?
|
| Exercise | 1 | 2016 | 673 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2011 | 108 | 0.020 |
Why?
|
| Salvage Therapy | 1 | 2011 | 134 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 881 | 0.020 |
Why?
|
| Animals | 1 | 2019 | 7542 | 0.020 |
Why?
|